For these reasons, androgen deprivation therapy (ADT) is an effective treatment in prostate cancer, although most patients progress to castration-resistant prostate cancer with an increase of AR expression levels and hypersensitivity to androgen-based therapies. The gene discussed is AR; the disease is prostate carcinoma.